Department of Chemistry, University of Missouri-Columbia, 125 Chemistry Building, Columbia, Missouri 65211, United States.
Chem Res Toxicol. 2012 Jan 13;25(1):197-206. doi: 10.1021/tx2004213. Epub 2011 Nov 22.
Heterocyclic N-oxides are an interesting class of antitumor agents that selectively kill the hypoxic cells found in solid tumors. The hypoxia-selective activity of the lead compound in this class, tirapazamine, stems from its ability to undergo intracellular one-electron reduction to an oxygen-sensitive drug radical intermediate. In the presence of molecular oxygen, the radical intermediate is back-oxidized to the parent molecule. Under hypoxic conditions, the extended lifetime of the drug radical intermediate enables its conversion to a highly cytotoxic DNA-damaging intermediate via a "deoxygenative" mechanism involving the loss of oxygen from one of its N-oxide groups. The natural product myxin is a phenazine di-N-oxide that displays potent antibiotic activity against a variety of organisms under aerobic conditions. In light of the current view of heterocyclic N-oxides as agents that selectively operate under hypoxic conditions, it is striking that myxin was identified from Sorangium extracts based upon its antibiotic properties under aerobic conditions. Therefore, we set out to examine the molecular mechanisms underlying the biological activity of myxin. We find that myxin causes bioreductively activated, radical-mediated DNA strand cleavage under both aerobic and anaerobic conditions. Our evidence indicates that strand cleavage occurs via a deoxygenative metabolism. We show that myxin displays potent cytotoxicity against the human colorectal cancer cell line HCT-116 under both aerobic and anaerobic conditions that is comparable to the cell-killing properties of tirapazamine under anaerobic conditions. This work sheds light on the processes by which the naturally occurring aromatic N-oxide myxin gains its potent antibiotic properties under aerobic conditions. Furthermore, these studies highlight the general potential for aromatic N-oxides to undergo highly cytotoxic deoxygenative metabolism following enzymatic one-electron reduction under aerobic conditions.
杂环 N-氧化物是一类很有意思的抗肿瘤药物,它们能够选择性地杀伤实体瘤中缺氧的细胞。该类药物中的先导化合物替拉扎胺之所以具有缺氧选择性,是因为它能够在细胞内经历单电子还原,生成一个对氧敏感的药物自由基中间体。在有分子氧的情况下,自由基中间体被重新氧化为母体分子。在缺氧条件下,药物自由基中间体的寿命延长,使其能够通过一种“脱氧”机制转化为一种高度细胞毒性的 DNA 损伤中间体,该机制涉及从其一个 N-氧化物基团中失去氧。天然产物米辛是一种吩嗪二 N-氧化物,在有氧条件下对多种生物体表现出很强的抗生素活性。鉴于杂环 N-氧化物目前被认为是在缺氧条件下选择性作用的药物,米辛是从索拉金属提取物中根据其在有氧条件下的抗生素特性被鉴定出来的,这一点令人震惊。因此,我们着手研究米辛生物活性的分子机制。我们发现,米辛在有氧和无氧条件下均能引起生物还原激活的、自由基介导的 DNA 链断裂。我们的证据表明,链断裂是通过脱氧代谢发生的。我们表明,米辛在有氧和无氧条件下对人结直肠癌细胞系 HCT-116 均表现出很强的细胞毒性,其杀伤效果与替拉扎胺在无氧条件下的细胞杀伤特性相当。这项工作阐明了天然芳香族 N-氧化物米辛在有氧条件下获得其强大抗生素特性的过程。此外,这些研究突出了芳香族 N-氧化物在有氧条件下经酶促单电子还原后发生高度细胞毒性脱氧代谢的普遍潜力。